Word

PHARMALEX

Status

Pending

Status Code

641

Status Date

Wednesday, February 21, 2024

Serial Number

98015957

Mark Type

4

Filing Date

Friday, May 26, 2023

Trademark Owner History

PharmaLex GmbH

Classifications

9 Software; automation software; artificial intelligence apparatus; information technology apparatus; computers; computer programs for data processing; computer software applications, downloadable; unified communications software; assistive software

35 Advertising, management of business for others, business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; support and advice in the context of drug distribution in retail and wholesale; providing outsourced office functions services for drug approval, manufacturing, distribution, security and monitoring; assistance and consultancy in the context of the retailing and wholesaling of medicines; Consultancy services in the fields of controlling and managing business information and implementing and managing databases

45 Regulatory compliance auditing; regulatory compliance consulting services; regulatory support and advice in the context of drug approval; submission of documents, reports and records required for drug approval by regulatory authorities (Regulatory compliance auditing); consultancy services in the fields of regulatory compliance and oversight; advisory services relating to regulatory affairs; regulatory maintenance of marketing authorizations following approval

44 Medical and veterinary services; pharmacy advice; providing information relating to the preparation and dispensing of medications; provision of pharmaceutical information; provision of information relating to medicine; consultancy and information services provided via the Internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; advisory services relating to pharmaceuticals; medical, diagnostic and pharmaceutical services and advice; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis and examinations; medical treatment services; medical services; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of illnesses; medical, diagnostic and pharmaceutical services and advice in the field of drug safety; providing information in the field of pharmacovigilance and adverse event reporting

42 Scientific and technological services and research and design relating thereto; scientific, technological, medical and pharmaceutical research and development services; industrial analysis and research services; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific, technological, medical and pharmaceutical research services and analysis services for scientific and technological purposes; biological research; clinical research; providing medical and scientific research information; provision of surveys (scientific); scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars, therapeutics; development of a web application for entering and evaluating informative texts for pharmaceuticals and medical products, in particular instructions for use, package inserts, specialist information and for the provision of various documents; database services, namely, storage of data in computer databases; conversion of data or documents from physical to electronic media; testing, inspection or research of pharmaceuticals and medicines; design, engineering, research, development and testing services; research in the field of gene therapy; quality assurance, quality control and quality management consultancy; research services relating to scientific work; preparation of scientific analyzes and evaluations; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; information technology services for the pharmaceutical and healthcare industries; scientific evaluation of drug efficacy; services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design; analysis and evaluation of product development; quality control testing; materials testing and evaluation; product safety testing; certification (quality control); quality testing of products for certification purposes; support and advice on drug safety and monitoring; consultancy services for the development and approval process of biological samples or chemical samples for therapeutic and diagnostic purpose; consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics; laboratory analysis service relating to the diagnosis and treatment of persons

Trademark Events

May 30, 2023

New Application Entered

Jun 28, 2023

New Application Office Supplied Data Entered

Feb 21, 2024

Non-Final Action Written

Feb 20, 2024

Assigned To Examiner

Feb 21, 2024

Non-Final Action E-Mailed

Feb 21, 2024

Notification Of Non-Final Action E-Mailed

May 10, 2024

Teas Change Of Correspondence Received

May 20, 2024

Application Extension Granted/Receipt Provided

Aug 16, 2024

Teas Response To Office Action Received

May 10, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 10, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

May 20, 2024

Application Extension To Response Period - Received